306 related articles for article (PubMed ID: 15606616)
1. The beneficial effects of treatment with all-trans-retinoic acid plus corticosteroid on autoimmune nephritis in NZB/WF mice.
Nozaki Y; Yamagata T; Yoo BS; Sugiyama M; Ikoma S; Kinoshita K; Funauchi M; Kanamaru A
Clin Exp Immunol; 2005 Jan; 139(1):74-83. PubMed ID: 15606616
[TBL] [Abstract][Full Text] [Related]
2. Anti-inflammatory effect of all-trans-retinoic acid in inflammatory arthritis.
Nozaki Y; Yamagata T; Sugiyama M; Ikoma S; Kinoshita K; Funauchi M
Clin Immunol; 2006 Jun; 119(3):272-9. PubMed ID: 16412693
[TBL] [Abstract][Full Text] [Related]
3. Rapamycin prevents the development of nephritis in lupus-prone NZB/W F1 mice.
Lui SL; Yung S; Tsang R; Zhang F; Chan KW; Tam S; Chan TM
Lupus; 2008 Apr; 17(4):305-13. PubMed ID: 18413412
[TBL] [Abstract][Full Text] [Related]
4. T cell cytokine imbalance towards production of IFN-gamma and IL-10 in NZB/W F1 lupus-prone mice is associated with autoantibody levels and nephritis.
Enghard P; Langnickel D; Riemekasten G
Scand J Rheumatol; 2006; 35(3):209-16. PubMed ID: 16766368
[TBL] [Abstract][Full Text] [Related]
5. Retinoic acid reduces autoimmune renal injury and increases survival in NZB/W F1 mice.
Kinoshita K; Yoo BS; Nozaki Y; Sugiyama M; Ikoma S; Ohno M; Funauchi M; Kanamaru A
J Immunol; 2003 Jun; 170(11):5793-8. PubMed ID: 12759464
[TBL] [Abstract][Full Text] [Related]
6. Activated protein C attenuates systemic lupus erythematosus and lupus nephritis in MRL-Fas(lpr) mice.
Lichtnekert J; Rupanagudi KV; Kulkarni OP; Darisipudi MN; Allam R; Anders HJ
J Immunol; 2011 Sep; 187(6):3413-21. PubMed ID: 21849682
[TBL] [Abstract][Full Text] [Related]
7. Tuftsin-phosphorylcholine (TPC) equally effective to methylprednisolone in ameliorating lupus nephritis in a mice model.
Shemer A; Kivity S; Shovman O; Bashi T; Perry O; Watad A; Ben-Ami Shor D; Volkov A; Barshack I; Bragazzi NL; Krule A; Fridkin M; Amital H; Blank M; Shoenfeld Y
Clin Exp Immunol; 2018 Aug; 193(2):160-166. PubMed ID: 29698559
[TBL] [Abstract][Full Text] [Related]
8. The Systemic Activation of Programmed Death 1-PD-L1 Axis Protects Systemic Lupus Erythematosus Model from Nephritis.
Liao W; Zheng H; Wu S; Zhang Y; Wang W; Zhang Z; Zhou C; Wu H; Min J
Am J Nephrol; 2017; 46(5):371-379. PubMed ID: 29069649
[TBL] [Abstract][Full Text] [Related]
9. Rapamycin attenuates the severity of established nephritis in lupus-prone NZB/W F1 mice.
Lui SL; Tsang R; Chan KW; Zhang F; Tam S; Yung S; Chan TM
Nephrol Dial Transplant; 2008 Sep; 23(9):2768-76. PubMed ID: 18445640
[TBL] [Abstract][Full Text] [Related]
10. CXCR3 promotes the production of IgG1 autoantibodies but is not essential for the development of lupus nephritis in NZB/NZW mice.
Moser K; Kalies K; Szyska M; Humrich JY; Amann K; Manz RA
Arthritis Rheum; 2012 Apr; 64(4):1237-46. PubMed ID: 22006377
[TBL] [Abstract][Full Text] [Related]
11. Soluble receptor for advanced glycation end products alleviates nephritis in (NZB/NZW)F1 mice.
Lee SW; Park KH; Park S; Kim JH; Hong SY; Lee SK; Choi D; Park YB
Arthritis Rheum; 2013 Jul; 65(7):1902-12. PubMed ID: 23553192
[TBL] [Abstract][Full Text] [Related]
12. Suppression of renal disease and mortality in the female NZB x NZW F1 mouse model of systemic lupus erythematosus (SLE) by chenodeoxycholic acid.
Suwannaroj S; Lagoo A; McMurray RW
Lupus; 2001; 10(8):562-7. PubMed ID: 11530998
[TBL] [Abstract][Full Text] [Related]
13. Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32).
Werwitzke S; Trick D; Sondermann P; Kamino K; Schlegelberger B; Kniesch K; Tiede A; Jacob U; Schmidt RE; Witte T
Ann Rheum Dis; 2008 Feb; 67(2):154-61. PubMed ID: 17557887
[TBL] [Abstract][Full Text] [Related]
14. Toxoplasma gondii infection inhibits the development of lupus-like syndrome in autoimmune (New Zealand Black x New Zealand White) F1 mice.
Chen M; Aosai F; Norose K; Mun HS; Ishikura H; Hirose S; Piao LX; Fang H; Yano A
Int Immunol; 2004 Jul; 16(7):937-46. PubMed ID: 15148287
[TBL] [Abstract][Full Text] [Related]
15. Roquinimex-mediated protection effect on the development of chronic graft-versus-host disease in mice is associated with induction of Th1 cytokine production and inhibition of proinflammatory cytokine production.
Xiao ZY; Zhou WX; Zhang YX; Cheng JP; He JF; Yang RF; Yun LH
Life Sci; 2007 Oct; 81(19-20):1403-10. PubMed ID: 17950363
[TBL] [Abstract][Full Text] [Related]
16. Atializumab, a humanized anti-aminoacyl-tRNA synthetase-interacting multifunctional protein-1 (AIMP1) antibody significantly improves nephritis in (NZB/NZW) F1 mice.
Mun CH; Kim JO; Ahn SS; Yoon T; Kim SJ; Ko E; Noh HD; Park YB; Jung HJ; Kim TS; Lee SW; Park SG
Biomaterials; 2019 Nov; 220():119408. PubMed ID: 31394431
[TBL] [Abstract][Full Text] [Related]
17. Sophorae radix reduces autoimmune response in NZB/w F1 systemic lupus erythematosus mouse model.
Ko E; Lee Y; Park N; Cho C; Yim YN; Kim J; Kim YS; Kim D; Shin MK; Hong MC; Bae H
Lupus; 2007; 16(5):335-41. PubMed ID: 17576735
[TBL] [Abstract][Full Text] [Related]
18. Bindarit retards renal disease and prolongs survival in murine lupus autoimmune disease.
Zoja C; Corna D; Benedetti G; Morigi M; Donadelli R; Guglielmotti A; Pinza M; Bertani T; Remuzzi G
Kidney Int; 1998 Mar; 53(3):726-34. PubMed ID: 9507220
[TBL] [Abstract][Full Text] [Related]
19. Mycophenolate mofetil combined with a cyclooxygenase-2 inhibitor ameliorates murine lupus nephritis.
Zoja C; Benigni A; Noris M; Corna D; Casiraghi F; Pagnoncelli M; Rottoli D; Abbate M; Remuzzi G
Kidney Int; 2001 Aug; 60(2):653-63. PubMed ID: 11473648
[TBL] [Abstract][Full Text] [Related]
20. Autoantibodies from long-lived 'memory' plasma cells of NZB/W mice drive immune complex nephritis.
Cheng Q; Mumtaz IM; Khodadadi L; Radbruch A; Hoyer BF; Hiepe F
Ann Rheum Dis; 2013 Dec; 72(12):2011-7. PubMed ID: 24114925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]